News View all news
FDA approves first treatment for inherited rare disease
FDA on Wednesday approved givosiran (Givlaari—Alnylam Pharmaceuticals) for the treatment of adults with acute hepatic porphyria. The rare genetic disorder causes the buildup of toxic porphyrin molecules, which are formed during the production of heme.
Invasive approach no better than meds to prevent cardiac events, study shows
Results from the international ISCHEMIA trial, the largest study to address the effect of opening blocked arteries in nonemergency situations, showed that patients who had invasive procedures to prevent cardiovascular events did no better than patients who received drug therapy treatment. The trial results were presented at the annual meeting of the American Heart Association over the weekend.
AHA/ACC publish quality measures for adults with high blood pressure
The American Heart Association (AHA) and the American College of Cardiology (ACC) jointly released a set of quality measures for adults with high blood pressure. The new measures were published this month in AHA’s Circulation: Cardiovascular Quality and Outcomes journal.
November 12, 2019
Take the Well-being Index for the first time…and a second, and a…
Your well-being isn’t a static snapshot of life. It’s a dynamic ebb and flow of experiences and events, and how we respond. By now, I hope you’ve all at least heard of the Well-being Index for…0 comments
November 5, 2019
APhA supports innovative legislation to reduce drug shortages
The American Pharmacists Association (APhA) today expressed its support for a bill that will provide new opportunities to address drug shortages and improve care. The Mitigating Emergency Drug Shortages (MEDS) Act, introduced by Sens. Susan Collins (R-ME) and Tina Smith (D-MN), aims to improve communications to pharmacists about drug shortages and mitigate the risks drug shortages pose to patient safety, among other benefits.
November 1, 2019
APhA Chief Operating Officer Elizabeth Keyes receives JFPS honor
American Pharmacists Association (APhA) Chief Operating Officer Elizabeth Keyes was recognized by the Joint Federal Pharmacy Seminar (JFPS) leadership during its recent annual meeting in Dallas, for her support of federal pharmacy programs, including JFPS.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.